ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 431,04
-0,79%
Dow Jones
41 938,45
-1,63%
DAX
20 214,79
-0,51%
Brent Oil
79,285
0,00%
Bitcoin
93 980,18
-0,77%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inogen Inc (INGN)

  7. Inogen Inc (INGN) Actualités

INGN

Inogen (INGN)

Inogen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INGN
DateHeureSourceTitreSymboleSociété
30/12/202414h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INGNInogen Inc
30/12/202414h30Business WireInogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance DeviceNASDAQ:INGNInogen Inc
03/12/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INGNInogen Inc
03/12/202423h01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:INGNInogen Inc
14/11/202417h12Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:INGNInogen Inc
08/11/202422h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INGNInogen Inc
07/11/202422h05Business WireInogen Announces Third Quarter 2024 Financial ResultsNASDAQ:INGNInogen Inc
07/11/202422h04GlobeNewswire Inc.Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, OperationsNASDAQ:INGNInogen Inc
04/11/202414h30Business WireInogen to Present at Upcoming Investor ConferencesNASDAQ:INGNInogen Inc
17/10/202414h30Business WireInogen to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:INGNInogen Inc
08/10/202414h30Business WireInogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POCNASDAQ:INGNInogen Inc
05/09/202414h30Business WireInogen Appoints Eric Pauls as Vice President of Sales, North AmericaNASDAQ:INGNInogen Inc
09/08/202422h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INGNInogen Inc
06/08/202422h05Business WireInogen Announces Second Quarter 2024 Financial ResultsNASDAQ:INGNInogen Inc
25/07/202401h43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INGNInogen Inc
16/07/202414h30Business WireInogen to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:INGNInogen Inc
03/07/202422h10Business WireInogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business DevelopmentNASDAQ:INGNInogen Inc
12/06/202423h00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INGNInogen Inc
03/06/202422h05Business WireInogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness RatioNASDAQ:INGNInogen Inc
31/05/202422h43Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:INGNInogen Inc
07/05/202422h05Business WireInogen Announces First Quarter 2024 Financial ResultsNASDAQ:INGNInogen Inc
10/04/202414h30Business WireInogen to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:INGNInogen Inc
25/03/202413h30Business WireInogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:INGNInogen Inc
07/03/202422h00Business WireInogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INGNInogen Inc
27/02/202422h05Business WireInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:INGNInogen Inc
14/02/202414h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INGNInogen Inc
30/01/202422h00Business WireInogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:INGNInogen Inc
24/01/202422h00Business WireInogen Names Michael Bourque as New Chief Financial OfficerNASDAQ:INGNInogen Inc
13/11/202314h30Business WireInogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEONASDAQ:INGNInogen Inc
09/11/202320h30Business WireInogen to Present at Upcoming Investor Conferences in November 2023NASDAQ:INGNInogen Inc
 Showing the most relevant articles for your search:NASDAQ:INGN

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
LR
Legrand
NYSE
MCD
McDonalds
EU
RI
Pernod Ricard
COIN
XRPUSD
Ripple
EU
VIV
Vivendi
NASDAQ
AMZN
Amazon.com
EU
EN
Bouygues
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
EU
ORA
Orange
EU
GLE
Societe Generale
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés